OrthoPediatrics saw the highest growth of 299% in patent filings and 99% in grants in October in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 299% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of OrthoPediatrics‘s patent filings and grants. Buy the databook here.
OrthoPediatrics has been focused on protecting inventions in Brazil(BR) with three publications in Q4 2023
The Brazil(BR) Patent Office dominates the patent filings and grants with nearly . The United States(US), South Korea(KR), European Patent Office(EPO), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where OrthoPediatrics is filings its patents. Among the top granted patent authorities, OrthoPediatrics has 75% of its grants in Brazil(BR) and 25% in South Korea(KR).
Johnson & Johnson and Roger P. Jackson could be the strongest competitors for OrthoPediatrics
In terms of grant share, OrthoPediatrics stands in ninth position among its competitors. Johnson & Johnson and Roger P. Jackson secured the top positions according to recent patent publication data.
Orthopedic devices related patents lead OrthoPediatrics portfolio
OrthoPediatrics has highest number of patents in orthopedic devices. For orthopedic devices, nearly 100% of patents were filed and 100% of patents were granted in Q4 2023.
For comprehensive analysis of OrthoPediatrics's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.